| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. | Wongkham, S. Boonla, C. Patrakitkomjorn, S. Howard, M. Sripa, B. Wongkham, C. Bhudhisawasdi, V. |
2003 | ||||
| 2. | PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin | Feng, L. Patrakitkomjorn, S. Saya, H. |
2004 | ||||
| 3. | The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway | Feng, L. Patrakitkomjorn, S. Saya, H. |
2005 | ||||
| 4. | Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 | Patrakitkomjorn, S. Kobayashi, D. Wilson, M.M. Saya, H. |
2008 | ||||
| 5. | A novel TFF2 splice variant (Delta EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Kamlua, S Patrakitkomjorn, S Jearanaikoon, P Menheniott, TR Giraud, AS Limpaiboon, T |
2012 | ||||
| 6. | A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Kamlua, S. Patrakitkomjorn, S. Jearanaikoon, P. Menheniott, T.R. Giraud, A.S. Limpaiboon, T. |
2012 | ||||
| 7. | Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. | Montira Janan Siriporn Proungvitaya Temduang Limpaiboon Tanakorn Proungvitaya Sittiruk Roytrakul Chaisiri Wongkham Patcharee Jearanaikoon Siri Chur-in Sopit Wongkham |
2012 | ||||
| 8. | Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. | Arthit Tolek Chaisiri Wongkham Siriporn Proungvitaya Atit Silsirivanit Sittiruk Roytrakul Narong Khuntikeo Sopit Wongkham |
2012 | ||||
| 9. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 | ||||
| 10. | Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. | Nichapavee Nutthasirikul Temduang Limpaiboon Chanvit Leelayuwat Siriporn Patrakitkomjorn Patcharee Jearanaikoon |
2013 | ||||
| 11. | DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma | T. Limpaiboon R. Amornpisutt S. Proungvitaya P. Jearanaikoon |
2014 | ||||
| 12. | Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. | Ammala Monsouvanh Tanakorn Proungvitaya Temduang Limpaiboon Chaisiri Wongkham Sopit Wongkham Vor Luvira Siriporn Proungvitaya |
2014 | ||||
| 13. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. | Rattaya Amornpisutt Siriporn Proungvitaya Patcharee Jearanaikoon Temduang Limpaiboon |
2015 | ||||
| 14. | Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. | Sombattheera, S Proungvitaya, T Limpaiboon, T Wongkham, S Wongkham, C Luvira, V Proungvitaya, S |
2015 | ||||
| 15. | Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma | Temduang Limpaiboon Chaiyachet Nanok Siriporn Proungvitaya Patcharee Jearanaikoon Ake Pugkhem Anucha Puapairoj |
2016 | ||||
| 16. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2016 | ||||
| 17. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 | ||||
| 18. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Proungvitaya, S Klinthong, W Proungvitaya, T Limpaiboon, T Jearanaikoon, P Roytrakul, S Wongkham, C Nimboriboonporn, A Wongkham, S |
2017 | ||||
| 19. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. | Chaiyachet Nanok Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 | ||||
| 20. | High levels of APEX1 in sera from patients with cholangiocarcinoma | Tanakorn Proungvitaya Siriporn Proungvitaya Doungdean Tummanatsakun Sittiruk Roytrakul |
2018 | ||||
| 21. | Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma | Chaiyachet Nanok Chanvit Leelayuwat Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 | ||||
| 22. | Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma | Siriporn Proungvitaya Tanakorn Proungvitaya Surangkana Sanmai Sittiruk Roytrakul |
2018 | ||||
| 23. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma | Wasenang, W Puapairoj, A Settasatian, C Proungvitaya, S Limpaiboon, T |
2019 | ||||
| 24. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 | ||||
| 25. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. | Chaiyarit, P. Patrakitkomjorn, S. Limpaiboon, T. |
2019 | ||||
| 26. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 | ||||
| 27. | The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. | Patrakitkomjorn, S. Jearanaikoon, P. Limpaiboon, T. |
2019 | ||||
| 28. | Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2020 | ||||
| 29. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior. | Buddhisa, S. Ngernpimai, S. Leelayuwat, C. Patrakitkomjorn, S. Chompoosor, A. Tippayawat, P. |
2020 | ||||
| 30. | Interleukin 25 (IL-25) expression in cholangiocarcinoma. | Supakit Kaewsarabhumi Tanakorn Proungvitaya Temduang Limpaiboon Patcharaporn Tippayawat Doungdean Tummanatsakun Attapol Titapun Prakasit Sa-Ngaimwibool Siriporn Proungvitaya |
2020 | ||||
| 31. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 | ||||
| 32. | Serum cystatin C as a potential marker for glomerular filtration rate in patients with cholangiocarcinoma | Ciin, MN Proungvitaya, T Limpaiboon, T Roytrakul, S Cha'on, U Tummanatsakun, D Proungvitaya, S |
2020 | ||||
| 33. | Bioinformatic Prediction of Signaling Pathways for Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) and Its Role in Cholangiocarcinoma Cells | Proungvitaya, T. Patrakitkomjorn, S. |
2021 | ||||
| 34. | Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis | Chanakankun, R. Proungvitaya, T. Seubwai, W. Wongwattanakul, M. Patrakitkomjorn, S. |
2021 | ||||
| 35. | Serum levels of cytokine-induced apoptosis inhibitor 1 (Ciapin1) as a potential prognostic biomarker of cholangiocarcinoma | Son Dinh An Truong Doungdean Tummanatsakun Tanakorn Proungvitaya Temduang Limpaiboon Molin Wongwattanakul Daraporn Chua-on Sittiruk Roytrakul Siriporn Proungvitaya |
2021 | ||||
| 36. | Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells. | Chua-On, D. Proungvitaya, T. Techasen, A. Limpaiboon, T. Patrakitkomjorn, S. |
2022 | ||||
| 37. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma | Lertpanprom, M Silsirivanit, A Tippayawat, P Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 | ||||
| 38. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. | Aung, T.M. Silsirivanit, A. Jusakul, A. Chan-On, W. Proungvitaya, T. Roytrakul, S. Proungvitaya, S. |
2022 | ||||
| 39. | Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis | Truong, S.D.A. Wongwattanakul, M. Proungvitaya, T. Limpaiboon, T. Roytrakul, S. Chua-On, D. Tummanatsakun, D. Proungvitaya, S. |
2022 | ||||
| 40. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 | ||||
| 41. | Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters. | Min-Oo, HH Aung, TM Wongwattanakul, M Maraming, P Proungvitaya, T Proungvitaya, S |
2023 | ||||
| 42. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers | Jannawan, A Silsirivanit, A Seubwai, W Wongwattanakul, M Proungvitaya, T Aung, TM Roytrakul, S Chiawiriyabunya, I Proungvitaya, S |
2023 | ||||
| 43. | Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. | Aung, TM Ngamjarus, C Proungvitaya, T Saengboonmee, C Proungvitaya, S |
2024 | ||||
| 44. | DNA aptamer-functionalized PDA nanoparticles: from colloidal chemistry to biosensor applications. | Zaw, O. Noon Shean Aye, N. Daduang, J. Proungvitaya, S. |
2024 | ||||
| 45. | Serum CCDC25 Levels as a Potential Marker for Metabolic Syndrome. | Phimphila, A Aung, TM Wongwattanakul, M Maraming, P Tavichakorntrakool, R Proungvitaya, T Daduang, J Proungvitaya, S |
2024 | Count | 30 | 29 | 26 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Serum MUC5AC mucin as a potential marker for cholangiocarcinoma | Wongkham, S. Boonla, C. Patrakitkomjorn, S. Howard, M. Sripa, B. Wongkham, C. Bhudhisawasdi, V. |
2003 |
Cancer Letters 1 (195), pp. 93-99 |
||||||||
| 2. | PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin | Feng, L. Patrakitkomjorn, S. Saya, H. |
2004 |
FEBS Letters 1-3 (557), pp. 275-282 |
||||||||
| 3. | The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway | Feng, L. Patrakitkomjorn, S. Saya, H. |
2005 |
Journal of Biological Chemistry 47 (280), pp. 39524-39533 |
||||||||
| 4. | Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2 | Patrakitkomjorn, S. Kobayashi, D. Wilson, M.M. Saya, H. |
2008 |
Journal of Biological Chemistry 14 (283), pp. 9399-9413 |
||||||||
| 5. | A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Kamlua, S. Patrakitkomjorn, S. Jearanaikoon, P. Menheniott, T.R. Giraud, A.S. Limpaiboon, T. |
2012 |
Oncology Reports 4 (27), pp. 1207-1212 |
||||||||
| 6. | Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nutthasirikul, N. Limpaiboon, T. Leelayuwat, C. Patrakitkomjorn, S. Jearanaikoon, P. |
2013 |
International Journal of Oncology 4 (42), pp. 1181-1188 |
||||||||
| 7. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2016 |
Tumor Biology 10 (37), pp. 13659-13667 |
||||||||
| 8. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Patrakitkomjorn, S. Sombattheera, S. Boonsiri, P. Limpaiboon, T. Wongkham, C. Titapun, A. Proungvitaya, T. |
2017 |
Oncology Letters 4 (14), pp. 4943-4948 |
||||||||
| 9. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Patrakitkomjorn, S. Proungvitaya, T. Limpaiboon, T. Jearanaikoon, P. Wongkham, C. |
2017 |
Oncology Letters 2 (14), pp. 2566-2572 |
||||||||
| 10. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for Cholangiocarcinoma | Nanok, C. Jearanaikoon, P. Patrakitkomjorn, S. Limpaiboon, T. |
2018 |
Molecular Medicine Reports 3 (17), pp. 4145-4153 |
||||||||
| 11. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma | Settasatian, C. Patrakitkomjorn, S. Limpaiboon, T. |
2019 |
Pathology Research and Practice 7 (215), pp. |
||||||||
| 12. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 |
Biomolecules 9 (9), pp. |
||||||||
| 13. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases | Chaiyarit, P. Patrakitkomjorn, S. Limpaiboon, T. |
2019 |
Clinical Epigenetics 1 (11), pp. |
||||||||
| 14. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Seubwai, W. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2019 |
Oncology Letters 6 (17), pp. 5275-5282 |
||||||||
| 15. | The upregulation of OCT4 in acidic extracellular pH is associated with gemcitabine resistance in cholangiocarcinoma cell lines | Patrakitkomjorn, S. Jearanaikoon, P. Limpaiboon, T. |
2019 |
Asian Pacific Journal of Cancer Prevention 9 (20), pp. 2745-2748 |
||||||||
| 16. | Apoptosis-inducing factor, mitochondrion-associated 3 (Aifm3) protein level in the sera as a prognostic marker of cholangiocarcinoma patients | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2020 |
Biomolecules 7 (10), pp. 1-12 |
||||||||
| 17. | Influence of gold nanoparticles with different surface charges on localization and monocyte behavior | Buddhisa, S. Ngernpimai, S. Leelayuwat, C. Patrakitkomjorn, S. Chompoosor, A. Tippayawat, P. |
2020 |
Bioconjugate Chemistry 4 (31), pp. 1133-1143 |
||||||||
| 18. | Interleukin 25 (Il-25) expression in cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Tippayawat, P. Titapun, A. Patrakitkomjorn, S. |
2020 |
Molecular and Clinical Oncology 6 (13), pp. 1-9 |
||||||||
| 19. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Jusakul, A. Titapun, A. Patrakitkomjorn, S. |
2020 |
Oncology Letters 1 (19), pp. 930-942 |
||||||||
| 20. | Serum cystatin C as a potential marker for glomerular filtration rate in patients with cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Chaon, U. Patrakitkomjorn, S. |
2020 |
International Journal of Hematology-Oncology and Stem Cell Research 3 (14), pp. 157-166 |
||||||||
| 21. | Bioinformatic prediction of signaling pathways for apurinic/apyrimidinic endodeoxyribonuclease 1 (Apex1) and its role in cholangiocarcinoma cells | Proungvitaya, T. Patrakitkomjorn, S. |
2021 |
Molecules 9 (26), pp. |
||||||||
| 22. | Kallikrein-11, in association with coiled-coil domain containing 25, as a potential prognostic marker for cholangiocarcinoma with lymph node metastasis | Chanakankun, R. Proungvitaya, T. Seubwai, W. Wongwattanakul, M. Patrakitkomjorn, S. |
2021 |
Molecules 11 (26), pp. |
||||||||
| 23. | Serum levels of cytokine-induced apoptosis inhibitor 1 (Ciapin1) as a potential prognostic biomarker of cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongwattanakul, M. Chua-On, D. Patrakitkomjorn, S. |
2021 |
Diagnostics 6 (11), pp. NA |
||||||||
| 24. | Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells | Chua-On, D. Proungvitaya, T. Techasen, A. Limpaiboon, T. Patrakitkomjorn, S. |
2022 |
Cancer Genomics and Proteomics 1 (19), pp. 35-49 |
||||||||
| 25. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma | Lertpanprom, M. | 2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 26. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells | Aung, T.M. Silsirivanit, A. Jusakul, A. Chan-On, W. Proungvitaya, T. Roytrakul, S. Proungvitaya, S. |
2022 |
Cancer Genomics and Proteomics 4 (19), pp. 490-502 |
||||||||
| 27. | Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis | Truong, S.D.A. Wongwattanakul, M. Proungvitaya, T. Limpaiboon, T. Roytrakul, S. Chua-On, D. Tummanatsakun, D. Proungvitaya, S. |
2022 |
Journal of Clinical Medicine 13 (11), pp. |
||||||||
| 28. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients | Silsirivanit, A. Jusakul, A. Lert-Itthiporn, W. Proungvitaya, T. Patrakitkomjorn, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 29. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers | Jannawan, A. | 2023 |
In Vivo 1 (37), pp. 294-303 |
||||||||
| 30. | DNA aptamer-functionalized PDA nanoparticles: from colloidal chemistry to biosensor applications | Zaw, O. Noon Shean Aye, N. Daduang, J. Proungvitaya, S. |
2024 |
Frontiers in Bioengineering and Biotechnology (12), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. | Wongkham, S Sheehan, JK Boonla, C Patrakitkomjorn, S Howard, M Kirkham, S Sripa, B Wongkham, C Bhudhisawasdi, V |
2003 |
Cancer letters 1 (195), pp. 93-9 |
|
| 2. | A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma. | Kamlua, S Patrakitkomjorn, S Jearanaikoon, P Menheniott, TR Giraud, AS Limpaiboon, T |
2012 |
Oncology reports 4 (27), pp. 1207-12 |
|
| 3. | Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. | Tolek, A Wongkham, C Proungvitaya, S Silsirivanit, A Roytrakul, S Khuntikeo, N Wongkham, S |
2012 |
Experimental biology and medicine (Maywood, N.J.) 10 (237), pp. 1142-9 |
|
| 4. | Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients. | Janan, M Proungvitaya, S Limpaiboon, T Proungvitaya, T Roytrakul, S Wongkham, C Jearanaikoon, P Chur-in, S Wongkham, S |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 107-14 |
|
| 5. | Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma. | Nutthasirikul, N Limpaiboon, T Leelayuwat, C Patrakitkomjorn, S Jearanaikoon, P |
2013 |
International journal of oncology 4 (42), pp. 1181-8 |
|
| 6. | Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma. | Monsouvanh, A Proungvitaya, T Limpaiboon, T Wongkham, C Wongkham, S Luvira, V Proungvitaya, S |
2014 |
Asian Pacific journal of cancer prevention : APJCP 21 (15), pp. 9511-5 |
|
| 7. | Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice. | Sombattheera, S Proungvitaya, T Limpaiboon, T Wongkham, S Wongkham, C Luvira, V Proungvitaya, S |
2015 |
Asian Pacific journal of cancer prevention : APJCP 4 (16), pp. 1367-70 |
|
| 8. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. | Amornpisutt, R Proungvitaya, S Jearanaikoon, P Limpaiboon, T |
2015 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (36), pp. 4973-8 |
|
| 9. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (37), pp. 13659-13667 |
|
| 10. | High expression of CCDC25 in cholangiocarcinoma tissue samples. | Proungvitaya, S Klinthong, W Proungvitaya, T Limpaiboon, T Jearanaikoon, P Roytrakul, S Wongkham, C Nimboriboonporn, A Wongkham, S |
2017 |
Oncology letters 2 (14), pp. 2566-2572 |
|
| 11. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma. | Proungvitaya, S Sombattheera, S Boonsiri, P Limpaiboon, T Wongkham, S Wongkham, C Titapun, A Proungvitaya, T |
2017 |
Oncology letters 4 (14), pp. 4943-4948 |
|
| 12. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. | Nanok, C Jearanaikoon, P Proungvitaya, S Limpaiboon, T |
2018 |
Molecular medicine reports 3 (17), pp. 4145-4153 |
|
| 13. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 |
Oncology letters 6 (17), pp. 5275-5282 |
|
| 14. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases. | Wasenang, W Chaiyarit, P Proungvitaya, S Limpaiboon, T |
2019 |
Clinical epigenetics 1 (11), pp. 39 |
|
| 15. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. | Wasenang, W Puapairoj, A Settasatian, C Proungvitaya, S Limpaiboon, T |
2019 |
Pathology, research and practice (), pp. 152451 |
|
| 16. | The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines. | Choodetwattana, P Proungvitaya, S Jearanaikoon, P Limpaiboon, T |
2019 |
Asian Pacific journal of cancer prevention : APJCP 9 (20), pp. 2745-2748 |
|
| 17. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. | Chanakankun, R Proungvitaya, T Chua-On, D Limpaiboon, T Roytrakul, S Jusakul, A Titapun, A Jarearnrat, A Proungvitaya, S |
2020 |
Oncology letters 1 (19), pp. 930-942 |
|
| 18. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior. | Srijampa, S Buddhisa, S Ngernpimai, S Leelayuwat, C Proungvitaya, S Chompoosor, A Tippayawat, P |
2020 |
Bioconjugate chemistry 4 (31), pp. 1133-1143 |
|
| 19. | Serum Cystatin C as a Potential Marker for Glomerular Filtration Rate in Patients with Cholangiocarcinoma. | Ciin, MN Proungvitaya, T Limpaiboon, T Roytrakul, S Cha'on, U Tummanatsakun, D Proungvitaya, S |
2020 |
International journal of hematology-oncology and stem cell research 3 (14), pp. 157-166 |
|
| 20. | Interleukin 25 (IL-25) expression in cholangiocarcinoma. | Kaewsarabhumi, S Proungvitaya, T Limpaiboon, T Tippayawat, P Tummanatsakun, D Titapun, A Sa-Ngaimwibool, P Proungvitaya, S |
2020 |
Molecular and clinical oncology 6 (13), pp. 84 |
|
| 21. | Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Tummanatsakun, D Araki, N Proungvitaya, S |
2022 |
Cancer genomics & proteomics 1 (19), pp. 35-49 |
|
| 22. | Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients. | Aung, TM Ciin, MN Silsirivanit, A Jusakul, A Lert-Itthiporn, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Frontiers in public health (10), pp. 836985 |
|
| 23. | Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. | Aung, TM Silsirivanit, A Jusakul, A Chan-On, W Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Cancer genomics & proteomics 4 (19), pp. 490-502 |
|
| 24. | High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma. | Lertpanprom, M Silsirivanit, A Tippayawat, P Proungvitaya, T Roytrakul, S Proungvitaya, S |
2022 |
Frontiers in public health (10), pp. 835914 |
|
| 25. | High Level of Serum Coiled-coil Domain Containing 25 (CCDC25) as a Diagnostic Marker for Cholangiocarcinoma But Not for Other Cancers. | Jannawan, A Silsirivanit, A Seubwai, W Wongwattanakul, M Proungvitaya, T Aung, TM Roytrakul, S Chiawiriyabunya, I Proungvitaya, S |
2023 |
In vivo (Athens, Greece) 1 (37), pp. 294-303 |
|
| 26. | Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters. | Min-Oo, HH Aung, TM Wongwattanakul, M Maraming, P Proungvitaya, T Proungvitaya, S |
2023 |
In vivo (Athens, Greece) 3 (37), pp. 1145-1155 |
|
| 27. | Serum CCDC25 Levels as a Potential Marker for Metabolic Syndrome. | Phimphila, A Aung, TM Wongwattanakul, M Maraming, P Tavichakorntrakool, R Proungvitaya, T Daduang, J Proungvitaya, S |
2024 |
In vivo (Athens, Greece) 2 (38), pp. 785-793 |
|
| 28. | Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. | Aung, TM Ngamjarus, C Proungvitaya, T Saengboonmee, C Proungvitaya, S |
2024 |
PloS one 5 (19), pp. e0303337 |
|
| 29. | DNA aptamer-functionalized PDA nanoparticles: from colloidal chemistry to biosensor applications. | Zaw, O Noon Shean Aye, N Daduang, J Proungvitaya, S Wongwattanakul, M Ngernyuang, N Daduang, S Shinsuphan, N Phatthanakun, R Jearanaikoon, N Maraming, P |
2024 |
Frontiers in bioengineering and biotechnology (12), pp. 1427229 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | A novel TFF2 splice variant (Delta EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma | Surasee Kamlua Siriporn Patrakitkomjorn Patcharee Jearanaikoon Trevelyan R. Menheniott Andrew S. Giraud Temduang Limpaiboon |
2012 |
ONCOLOGY REPORTS 4.0 (27.0), pp. 1207.0-1212.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 2. | Serum Adhesion Molecule-1 (ICAM-1) as a Potential Prognostic Marker for Cholangiocarcinoma Patients | Montira Janan Siriporn Proungvitaya Temduang Limpaiboon Tanakorn Proungvitaya Sittiruk Roytrakul Chaisiri Wongkham Patcharee Jearanaikoon Siri Chur-in Sopit Wongkham |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 107.0-114.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 3. | Serum alpha(1)beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma | Arthit Tolek Chaisiri Wongkham Siriporn Proungvitaya Atit Silsirivanit Sittiruk Roytrakul Narong Khuntikeo Sopit Wongkham |
2012 |
EXPERIMENTAL BIOLOGY AND MEDICINE 10.0 (237.0), pp. 1142.0-1149.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 4. | Ratio disruption of the Delta 133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma | Nichapavee Nutthasirikul Temduang Limpaiboon Chanvit Leelayuwat Siriporn Patrakitkomjorn Patcharee Jearanaikoon |
2013 |
INTERNATIONAL JOURNAL OF ONCOLOGY 4.0 (42.0), pp. 1181.0-1188.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 5. | DNA methylation levels of OPCML and SFRP1 as diagnostic biomarkers in cholangiocarcinoma | T. Limpaiboon R. Amornpisutt S. Proungvitaya P. Jearanaikoon |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S98-S98 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Serum Cathepsin B to Cystatin C Ratio as a Potential Marker for the Diagnosis of Cholangiocarcinoma | Ammala Monsouvanh Tanakorn Proungvitaya Temduang Limpaiboon Chaisiri Wongkham Sopit Wongkham Vor Luvira Siriporn Proungvitaya |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 21.0 (15.0), pp. 9511.0-9515.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 7. | DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma | Rattaya Amornpisutt Siriporn Proungvitaya Patcharee Jearanaikoon Temduang Limpaiboon |
2015 |
TUMOR BIOLOGY 7.0 (36.0), pp. 4973.0-4978.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 8. | Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma | Temduang Limpaiboon Chaiyachet Nanok Siriporn Proungvitaya Patcharee Jearanaikoon Ake Pugkhem Anucha Puapairoj |
2016 |
CANCER RESEARCH (76.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Daraporn Chua-on Tanakorn Proungvitaya Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sungkhamanon Siriporn Proungvitaya |
2016 |
TUMOR BIOLOGY 10.0 (37.0), pp. 13659.0-13667.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 10. | Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma | Siriporn Proungvitaya Sutthikan Sombattheera Patcharee Boonsiri Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Attapol Titapun Tanakorn Proungvitaya |
2017 |
ONCOLOGY LETTERS 4.0 (14.0), pp. 4943.0-4948.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 11. | High expression of CCDC25 in cholangiocarcinoma tissue samples | Siriporn Proungvitaya Wachiraya Klinthong Tanakorn Proungvitaya Temduang Limpaiboon Patcharee Jearanaikoon Sittiruk Roytrakul Chaisiri Wongkham Anongporn Nimboriboonporn Sopit Wongkham |
2017 |
ONCOLOGY LETTERS 2.0 (14.0), pp. 2566.0-2572.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 12. | Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma | Chaiyachet Nanok Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 |
MOLECULAR MEDICINE REPORTS 3.0 (17.0), pp. 4145.0-4153.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 13. | High levels of APEX1 in sera from patients with cholangiocarcinoma | Tanakorn Proungvitaya Siriporn Proungvitaya Doungdean Tummanatsakun Sittiruk Roytrakul |
2018 |
CANCER SCIENCE (109.0), pp. 955.0-955.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Methylation of UCHL1 as a prognostic biomarker for cholangiocarcinoma | Chaiyachet Nanok Chanvit Leelayuwat Patcharee Jearanaikoon Siriporn Proungvitaya Temduang Limpaiboon |
2018 |
CANCER SCIENCE (109.0), pp. 243.0-243.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | Serum pyruvate dehydrogenase kinase 3 as a prognostic marker for cholangiocarcinoma | Siriporn Proungvitaya Tanakorn Proungvitaya Surangkana Sanmai Sittiruk Roytrakul |
2018 |
CANCER SCIENCE (109.0), pp. 955.0-955.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16. | Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma | Wiphawan Wasenang Anucha Puapairoj Chatri Settasatian Siriporn Proungvitaya Temduang Limpaiboon |
2019 |
PATHOLOGY RESEARCH AND PRACTICE 7.0 (215.0), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 17. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
BIOMOLECULES 9.0 (9.0), pp. |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 18. | Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases | Wiphawan Wasenang Ponlatham Chaiyarit Siriporn Proungvitaya Temduang Limpaiboon |
2019 |
CLINICAL EPIGENETICS (11.0), pp. |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 19. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
ONCOLOGY LETTERS 6.0 (17.0), pp. 5275.0-5282.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 20. | Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients | Daraporn Chua-on Tanakorn Proungvitaya Doungdean Tummanatsakun Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2020 |
BIOMOLECULES 7.0 (10.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 21. | Influence of Gold Nanoparticles with Different Surface Charges on Localization and Monocyte Behavior | Sukanya Srijampa Surachat Buddhisa Sawinee Ngernpimai Chanvit Leelayuwat Siriporn Proungvitaya Apiwat Chompoosor Patcharaporn Tippayawat |
2020 |
BIOCONJUGATE CHEMISTRY 4.0 (31.0), pp. 1133.0-1143.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 22. | Interleukin 25 (IL-25) expression in cholangiocarcinoma | Supakit Kaewsarabhumi Tanakorn Proungvitaya Temduang Limpaiboon Patcharaporn Tippayawat Doungdean Tummanatsakun Attapol Titapun Prakasit Sa-Ngaimwibool Siriporn Proungvitaya |
2020 |
MOLECULAR AND CLINICAL ONCOLOGY 6.0 (13.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 23. | Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma | Ravinnipa Chanakankun Tanakorn Proungvitaya Daraporn Chua-On Temduang Limpaiboon Sittiruk Roytrakul Apinya Jusakul Attapol Titapun Apiwat Jarearnrat Siriporn Proungvitaya |
2020 |
ONCOLOGY LETTERS 1.0 (19.0), pp. 930.0-942.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 24. | Bioinformatic Prediction of Signaling Pathways for Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) and Its Role in Cholangiocarcinoma Cells | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Siriporn Proungvitaya |
2021 |
MOLECULES 9.0 (26.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 25. | Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis | Saeranee Siriphak Ravinnipa Chanakankun Tanakorn Proungvitaya Sittiruk Roytrakul Doungdean Tummanatsakun Wunchana Seubwai Molin Wongwattanakul Siriporn Proungvitaya |
2021 |
MOLECULES 11.0 (26.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma | Son Dinh An Truong Doungdean Tummanatsakun Tanakorn Proungvitaya Temduang Limpaiboon Molin Wongwattanakul Daraporn Chua-on Sittiruk Roytrakul Siriporn Proungvitaya |
2021 |
DIAGNOSTICS 6.0 (11.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ | ||
|---|---|---|---|---|---|---|
| 1. | การรักษาแบบมุ่งเป้าสำหรับผู้ป่วยมะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ นายธนกร ปรุงวิทยา รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. วันชนะ สืบไวย |
ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | เป้าหมายการพัฒนายาเพื่อเพิ่มประสิทธิภาพการรักษามะเร็งท่อน้ำดี |
รศ.ดร. ศิริพร ปรุงวิทยา ศ.ดร. โสพิศ วงศ์คำ นายธนกร ปรุงวิทยา รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 3. | กรดน้ำดี : เป้าหมายการพัฒนายาเพื่อเพิ่มประสิทธิภาพการรักษามะเร็งท่อน้ำดี |
รศ.ดร. ศิริพร ปรุงวิทยา ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ นายธนกร ปรุงวิทยา ศ.ดร. เต็มดวง ลิ้มไพบูลย์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2558 | ทุนงบประมาณแผ่นดินประจำปี 2558 | |
| 4. | การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. อุบล ชาอ่อน รศ.ดร. ศิริพร ปรุงวิทยา |
ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 5. | บทบาทของมะเร็งท่อน้ำดีในการควบคุมระบบภูมิคุ้มกันต่อการดำเนินโรคเพื่อเป็นเป้าหมายในการรักษา |
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ศิริพร ปรุงวิทยา |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 6. | โปรตีนในไมโทคอนเดรียเพื่อเป้าหมายในการรักษามะเร็งท่อน้ำดี |
รศ.ดร. ศิริพร ปรุงวิทยา นายธนกร ปรุงวิทยา ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 7. | การค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดีการค้นหาโมเลกุลเป้าหมายเพื่อการรักษามะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. วันชนะ สืบไวย นายธนกร ปรุงวิทยา นางสาวภัทรินทร์ โพธิพันธุ์ ดร. ปวีณา ดานะ นางสาวปิยะนาฏ บุญเนตร นางสาววรพร แสนทวีสุข นางสาวอัญชลี ต้นศรี นางสาวอุบลรัตน์ ธำรงวรางกูรนายมารุตพงศ์ นางสาวสมสิริ อินทรมณี ดร. จารุพงษ์ แสงบุญมี นายฉัตรชัย ภู่มาก ผศ.ดร. อุบล ชาอ่อน รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ |
ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 8. | บทบาทของมะเร็งท่อน้ำดีในการควบคุมระบบภูมิคุ้มกันต่อการดำเนินของมะเร็งและการนำไปใช้เป็นเป้าหมายในการรักษามะเร็ง. |
ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ นางสาวภัทรินทร์ โพธิพันธุ์ นางสาววรพร แสนทวีสุข ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ รศ.ดร. ศิริพร ปรุงวิทยา |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 9. | การพัฒนาการตรวจวินิจฉัยและการรักษามะเร็งท่อน้ำดีโดยโมเลกุลเป้าหมายแบบองค์รวม |
รศ.ดร. ศิริพร ปรุงวิทยา ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ ศ.ดร. เต็มดวง ลิ้มไพบูลย์ ผศ.ดร.พญ. กุลธิดา เวทีวุฒาจารย์ ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ ผศ.ดร. อุบล ชาอ่อน นายธนกร ปรุงวิทยา ดร. สิทธิรักษ์ รอยตระกูล ดร. ปวีณา ดานะ นายฉัตรชัย ภู่มาก นางสาวภัคสิรี สรณารักษ์ น.ส. เสาวลักษณ์ สายสมบูรณ์ นายจิตรภาณุ มณีสาร นางสาววรพร แสนทวีสุข นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ นางสาวอรสา พนาวัน |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 10. | ชุดตรวจตัวบ่งชี้ชีวภาพในเลือดแบบองค์รวมเพื่อวินิจฉัยและพยากรณ์โรค มะเร็งท่อน้ำดี |
ศ.ดร. โสพิศ วงศ์คำ รศ.ดร. ชัยศิริ วงศ์คำ รศ.ดร. ศิริพร ปรุงวิทยา ผศ.ดร. กัลยาณี สวรรยาวิสุทธิ์ ผศ.ดร. วันชนะ สืบไวย ผศ.ดร. อาทิตย์ ศิลป์ศิริวานิชย์ นายธนกร ปรุงวิทยา นางสาวศศิประภา วัฒนวิเศษ นางสาวกรัณฑรัตน์ ธีรวิโรจน์ |
โครงการ | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |